11 insiders reported 17 Form 4 transactions for BRAINSTORM CELL THERAPEUTICS INC. (BCLI) over the past 18 months (most recent 2026-05-29). Recent activity: ARBEL IRIT (Director) Buy 120,000 shares, Lebovits Chaim (President & CEO) Buy 1.8M shares, Yablonka Uri (EVP & Chief Business Officer) Buy 150,000 shares, Patlis Alla (See Remarks) Buy 100,000 shares, FRENKEL JACOB A (Director) Buy 200,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-29 | ARBEL IRIT | Director | Buy | 120,000 | $0 |
| 2026-05-29 | Lebovits Chaim | President & CEO | Buy | 1.8M | $0 |
| 2026-05-29 | Yablonka Uri | EVP & Chief Business Officer | Buy | 150,000 | $0 |
| 2026-05-29 | Patlis Alla | See Remarks | Buy | 100,000 | $0 |
| 2026-05-29 | FRENKEL JACOB A | Director | Buy | 200,000 | $0 |
| 2025-01-07 | Dagher Ibrahim B. | Chief Medical Officer | Buy | 50,000 | $0 |
| 2025-01-03 | Polverino Anthony J. | Director | Buy | 24,000 | $0 |
| 2025-01-03 | HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | Buy | 50,000 | $0 |
| 2025-01-03 | Lebovits Chaim | President & CEO | Buy | 120,000 | $0 |
| 2025-01-03 | ARBEL IRIT | Director | Buy | 30,666 | $0 |
| 2025-01-03 | Yablonka Uri | EVP & Chief Business Officer | Buy | 40,000 | $0 |
| 2025-01-03 | Yablonka Uri | EVP & Chief Business Officer | Buy | 20,000 | $0 |
| 2025-01-03 | Lindborg Stacy | Director | Buy | 20,000 | $0 |
| 2025-01-03 | Naor Nir | Director | Buy | 30,666 | $0 |
| 2025-01-03 | FRENKEL JACOB A | Director | Buy | 40,000 | $0 |
| 2025-01-03 | Bairu Menghisteab | Director | Buy | 24,000 | $0 |
| 2025-01-03 | Patlis Alla | See Remarks | Buy | 40,000 | $0 |
Source: SEC Form 4 filings · as of 2026-05-29
